what to avoid on retatrutide How Does Work? Doctor Explains Why It's So Effective What Are the Risks of

This assumes no unexpected safety signals emerge from ongoing trials

Storage and handling instructions vary by pharmacy, affecting medication stability and potency

4 weeks Minimum interval between dose increases 2mg to 12mg Phase 2 dose range (Jastreboff 2023) ~12 weeks Time to reach 12mg on standard protocol 24.2% Weight loss at 12mg, 48 weeks (Phase 2) Investigational Drug Warning Retatrutide (LY3437943) is not FDA-approved as of April 2026

Eating smaller meals, avoiding very fatty foods, and staying hydrated may help

At the same time, the visible nature of weight loss can reinforce adherence, at least in the early stages

Doses above 12 mg have not been systematically studied and are not recommended